Clinical trial
A Phase II Study of Axitinib as Maintenance Treatment for Patients With Metastatic Colorectal Carcinoma
NCT01483638 is registered in ClinicalTrials.gov with Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Axitinib as Maintenance Treatment for Patients With Metastatic Colorectal Carcinoma
- Lead sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- September 30, 2015
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal carcinoma